13F filer · CIK 1802528
Fairmount Funds Management LLC
WEST CONSHOHOCKEN, PA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$1.5B
+$128.6M vs prior
Positions
12
New / sold out
1 / 1
Added / reduced
1 / 0
Turnover
2.7%
buys $39.7M · sells $202.7M
Top-10 weight
97.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | VIRIDIAN THERAPEUTICS INC | +1,176,470 | +30.1% | +$21.6M |
| New | FAETH THERAPEUTICS INC | +722,020 | – | +$18.1M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SPYRE THERAPEUTICS INC | -4,018,101 | -100.0% | $-202.7M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ORUKA THERAPEUTICS INCCOM | 3,705,262 | $352.6M | 23.31% |
| 2 | DIANTHUS THERAPEUTICS INCCOM | 2,537,191 | $247.3M | 16.35% |
| 3 | DAMORA THERAPEUTICS INCCOM NEW | 8,713,000 | $226.6M | 14.98% |
| 4 | COGENT BIOSCIENCES INCCOM | 5,503,418 | $213.0M | 14.08% |
| 5 | JADE BIOSCIENCES INCCOM NEW | 4,553,494 | $101.2M | 6.69% |
| 6 | ENLIVEN THERAPEUTICS INCCOM | 1,855,644 | $94.2M | 6.22% |
| 7 | VIRIDIAN THERAPEUTICS INCCOM | 5,090,928 | $93.5M | 6.18% |
| 8 | ZENAS BIOPHARMA INCCOM | 2,359,025 | $59.9M | 3.96% |
| 9 | CRESCENT BIOPHARMA INC.COM | 2,747,866 | $49.5M | 3.27% |
| 10 | APOGEE THERAPEUTICS INCCOM | 298,647 | $39.6M | 2.62% |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.